BaumjohannLab's Avatar

BaumjohannLab

@baumjohannlab

Research on T and B cells in immunity and autoimmunity in the lab of Dirk Baumjohann at University Hospital Bonn & Cluster of Excellence ImmunoSensation @immunosens.bsky.social #TfhCells #GCs #ImmuneOrganoids https://BaumjohannLab.de

2,356
Followers
916
Following
26
Posts
18.11.2024
Joined
Posts Following

Latest posts by BaumjohannLab @baumjohannlab

Looking forward to two exciting talks by
Jens Geginat (Milan) and Ralf Schmidt (Vienna) in the @efis-immunology.bsky.social EFIS-IL study group T-Cell Connect Europe online lecture series TODAY at 5pm CET. Details: www.t-cells.eu

03.03.2026 07:33 πŸ‘ 4 πŸ” 3 πŸ’¬ 0 πŸ“Œ 1
Preview
Tissue and Spatial Immunology | Keystone Symposia Join us at the Keystone Symposia on Tissue and Spatial Immunology, February 2027, in Banff, with field leaders!

Excited to organize @keystoneSymposia.bsky.social Tissue and Spatial Immunology with @leilaakkari.bsky.social and Hai Qi in February 2027! Join us to explore emerging research in Banff! keysym.us/KSSpatialImmune27 #KSSpatialImmune27

01.03.2026 06:55 πŸ‘ 9 πŸ” 2 πŸ’¬ 0 πŸ“Œ 0
Preview
Spatial Profiling of Germinal Centers in Mouse Secondary Lymphoid Organs Using MACSima Imaging Cyclic Staining Technology We developed a 50-plex imaging protocol using the MACSima platform to characterize the microarchitecture of germinal centers in secondary lymphoid tissues. This workflow combines tissue processing, a...

Our workflow to image and analyse germinal centres using a 50-plex cyclic staining protocol now out. Work led by Isabel San MartΓ­n Molina & Edith Marcial JuΓ‘rez with @babrahaminst.bsky.social imaging facility scientists Simon Walker & Hanneke Okkenhaug.
onlinelibrary.wiley.com/doi/10.1002/...

25.02.2026 07:22 πŸ‘ 8 πŸ” 1 πŸ’¬ 0 πŸ“Œ 1

Ever wondered what happens if you remove Tfh cells from established germinal centres?

26.01.2026 02:20 πŸ‘ 25 πŸ” 7 πŸ’¬ 4 πŸ“Œ 1
Fine-tuning BACH2 dosage balances stemness and effector function to enhance antitumor T cell therapy

Fine-tuning BACH2 dosage balances stemness and effector function to enhance antitumor T cell therapy

Thrilled to share our latest work: Fine-tuning BACH2 dosage balances stemness and effector function to enhance antitumor T cell therapy - now online in Nature Immunology. Led by Alberto Conti, Alex Evans and Teresa von Linde in the lab. www.nature.com/articles/s41...

16.01.2026 12:00 πŸ‘ 21 πŸ” 6 πŸ’¬ 2 πŸ“Œ 2
Post image

Finally, my PhD project is published! πŸŽ‰

I am thankful to all the collaborators who made this possible!

www.nature.com/articles/s41...

@natcomms.nature.com
#dendriticcells #immunesynapse #centrosome

15.01.2026 07:39 πŸ‘ 11 πŸ” 4 πŸ’¬ 2 πŸ“Œ 0
T-Cell Connect Europe EFIS-IL study group T CELL CONNECT EUROPE (TCC_EUROPE)

Looking forward to two exciting talks by @carovinuesa.bsky.social and Dirk Elewaut in the EFIS-IL study group T-Cell Connect Europe online lecture series TODAY at 5pm CET t-cells.eu

06.01.2026 08:55 πŸ‘ 6 πŸ” 1 πŸ’¬ 0 πŸ“Œ 0
Post image

@biorxivpreprint.bsky.social Dysregulated localization of Tfh and B cells in lymph nodes of Idiopathic multicentric Castleman disease patients
www.biorxiv.org/content/10.6... @davidfajgenbaum.bsky.social

16.12.2025 04:30 πŸ‘ 6 πŸ” 3 πŸ’¬ 0 πŸ“Œ 0
Post image

πŸš€ New preprint!
The Human Cytokine Dictionary - 9.7M cells, 12 donors, 90 cytokines - our largest human single-cell perturbation atlas yet. Users can map cytokine activity in their own data. Huge thanks to Lukas, SΓΆren, Larsen, Parse Bio & Seelig lab!
πŸ”— www.biorxiv.org/content/10.6...

15.12.2025 22:42 πŸ‘ 49 πŸ” 12 πŸ’¬ 0 πŸ“Œ 1
Post image

πŸŽ‰ The new yEFIS website is now live! 🌐

We’re happy to share that our new website is officially online, check it out πŸ‘‰https://www.yefis.org/

10.12.2025 15:40 πŸ‘ 8 πŸ” 3 πŸ’¬ 1 πŸ“Œ 1
Post image

@biorxivpreprint.bsky.social Access to germinal center IL-4 microniches drives tissue-divergence of IgE memory responses
www.biorxiv.org/content/10.6...

06.12.2025 04:26 πŸ‘ 11 πŸ” 2 πŸ’¬ 0 πŸ“Œ 0
Post image

@biorxivpreprint.bsky.social BCL6 is required for the development of functionally responsive IgM+ GC-independent Memory B Cells @marionpepper.bsky.social
www.biorxiv.org/content/10.1...

06.12.2025 04:28 πŸ‘ 8 πŸ” 3 πŸ’¬ 0 πŸ“Œ 1
Post image Post image Post image Post image

The Cluster Science Days 2025 were a very joyful event bringing together our Bonn scientists to share ideas and to network.

During the event the Cluster participants could enjoy talks, interactive poster sessions and a fun evening program in a comfortable atmosphere fostering scientific exchange.

20.11.2025 10:53 πŸ‘ 7 πŸ” 3 πŸ’¬ 0 πŸ“Œ 1
Post image

@natrevimmunol.nature.com Guidelines for T cell nomenclature
www.nature.com/articles/s41...

18.11.2025 16:00 πŸ‘ 27 πŸ” 12 πŸ’¬ 0 πŸ“Œ 1
Video thumbnail

πŸ—¨οΈ Just published in Nature Biotechnology: Our CellWhisperer AI enables chat-based analysis of single-cell sequencing data. You can talk to your cells & figure out the biology without writing any computer code. Paper here: www.nature.com/articles/s41.... Annotated walkthrough in a thread below (1/11)

11.11.2025 12:52 πŸ‘ 62 πŸ” 36 πŸ’¬ 2 πŸ“Œ 2
Post image

Registration is open for the Spring School on Immunology, hosted by DGfI
March 15–20, 2026 | Ettal, Bavaria
πŸŽ“ An intensive training course for PhDs, postdocs & clinician scientists
Apply by 15 Nov 2025 β†’ https://loom.ly/LxBXUfI
@dgfi-org.bsky.social

11.11.2025 09:48 πŸ‘ 3 πŸ” 2 πŸ’¬ 0 πŸ“Œ 0
Preview
Engineering and biofabrication of early cancer models Nature Reviews Bioengineering, Published online: 03 November 2025; doi:10.1038/s44222-025-00371-wEarly cancer biology and detection research is limited owing to a lack of clinical samples from pre-malignant and early-stage tumours. This Review discusses engineered in vitro systems that mimic early disease stages to investigate tumour progression and identify biomarkers for early cancer detection.

ICYMI: Engineering and biofabrication of early cancer models

04.11.2025 16:43 πŸ‘ 4 πŸ” 3 πŸ’¬ 0 πŸ“Œ 0
Post image

@biorxivpreprint.bsky.social Lymphatic constraint of germinal centers optimizes protective antibody responses
www.biorxiv.org/content/10.1... @thelundlab.bsky.social
@nyulangone.bsky.social @carlanowosad.bsky.social

06.11.2025 02:48 πŸ‘ 13 πŸ” 3 πŸ’¬ 0 πŸ“Œ 2
CD8 T cells produce IFNg and CXCL13 in TLS

CD8 T cells produce IFNg and CXCL13 in TLS

What mechanisms drive checkpoint inhibitor-associated interstitial nephritis (ICI-AIN)?
In our preprint, we identify CD8 T cells as a central player, inducing a proinflammatory myeloid cell state by IFNg and structuring lymphoid aggregates by CXCL13.

www.biorxiv.org/content/10.1...
1/n
#Nephsky πŸ§ͺ

05.11.2025 18:23 πŸ‘ 5 πŸ” 4 πŸ’¬ 1 πŸ“Œ 0
Preview
Junior Group Leader for RNA-Biology, RNA-Technology or RNA-Medicine (f/m/d) - WΓΌrzburg (Stadt), Bayern (DE) job with Helmholtz-Institut fΓΌr RNA-basierte Infektionsforschung (HIRI) | 12844907 #RNAexcellence Junior Group Leader Positions (f/m/d) Job advertisement no.:Β Β  089/2025 Starting date:Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β  As soon as possible. The con...

🚨 A fantastic opportunity to join HIRI to start your research group on RNA Biology πŸ‘‡ www.nature.com/naturecareer...

27.10.2025 21:55 πŸ‘ 16 πŸ” 20 πŸ’¬ 0 πŸ“Œ 0
Post image

Arai, Kawakami, Sakaguchi (2025 #Nobel laureate) and colleagues show that oral antigen exposure combined with CD28 costimulation blockade generates functionally stable antigen-specific CD101⁺ pTreg cells even in previously antigen-sensitized hosts. rupress.org/jem/article/...

21.10.2025 17:01 πŸ‘ 7 πŸ” 3 πŸ’¬ 2 πŸ“Œ 1
Preview
E15 Groups The Helmholtz Institute for RNA-based Infection Researchopens a call for

Looking to start your own lab? 🧬πŸ§ͺ The Helmholtz Institute WΓΌrzburg (HIRI) is offering group leader positions in RNA biology, RNA medicine & RNA technology. Apply by October 31 at www.helmholtz-hiri.de/en/jobs-tale...

13.10.2025 13:30 πŸ‘ 18 πŸ” 27 πŸ’¬ 0 πŸ“Œ 0
Preview
Tertiary lymphoid structures support the development of allergen-specific progenitor CD4+ T cells Tissue-resident memory CD4+ T cells (TRM) are key sentinels of the adaptive immune response that provide a rapid, robust inflammatory response upon reactivation in non-lymphoid tissues. While CD4+ TRM...

Asthma is a chronic disease characterized by acute, intermittent, recurrent episodes of airway inflammation. A decade of work developing the tools, techniques and collaborations needed to figure out how CD4+ T cells in the lungs propagate disease can be found here:
www.biorxiv.org/content/10.1...

10.10.2025 19:22 πŸ‘ 43 πŸ” 17 πŸ’¬ 1 πŸ“Œ 1
Job announcement: The image has a solid dark blue background with a clean, minimal layout. In the top left corner, the word β€œJOBS” appears in all-capital red sans-serif text. Below, large white sans-serif text spans several lines and reads: β€œThree Independent Group Leaders in Bioengineering Approaches to Human Health m/f/d.” Near the bottom left, smaller white sans-serif text reads: β€œApply by November 16, 2025,” followed by β€œMax DelbrΓΌck Center (Berlin-Buch)” in lighter gray. In the bottom right corner is the Max DelbrΓΌck Center logo in white and blue.

Job announcement: The image has a solid dark blue background with a clean, minimal layout. In the top left corner, the word β€œJOBS” appears in all-capital red sans-serif text. Below, large white sans-serif text spans several lines and reads: β€œThree Independent Group Leaders in Bioengineering Approaches to Human Health m/f/d.” Near the bottom left, smaller white sans-serif text reads: β€œApply by November 16, 2025,” followed by β€œMax DelbrΓΌck Center (Berlin-Buch)” in lighter gray. In the bottom right corner is the Max DelbrΓΌck Center logo in white and blue.

πŸš€ WE ARE HIRING 3️⃣ Independent Group Leaders for #mdcBerlin's new cutting-edge Bioengineering Cluster within our Biomedical Engineering Program.

Lead cutting-edge research at the interface of biology, engineering, and medicine in Berlin.

πŸ‘‰ Apply now: www.mdc-berlin.de/career/jobs/...

09.10.2025 11:00 πŸ‘ 14 πŸ” 23 πŸ’¬ 0 πŸ“Œ 1

Thanks @10xgenomics.bsky.social for the shout out and for making your data publicly available

Why waste precious resources ($$) to reinvent data that already exists? Cool human datasets ready to go

(Although now we have scratched the spatial itch, we may need to do more @chinweetan.bsky.social πŸ€”)

09.10.2025 09:54 πŸ‘ 12 πŸ” 2 πŸ’¬ 0 πŸ“Œ 0
Post image

Temporal and context-dependent requirements for the transcription factor Foxp3 expression in regulatory T cells @natimmunol.nature.com @yuripritykin.bsky.social Rudensky @princetonupress.bsky.social @mskcancercenter.bsky.social www.nature.com/articles/s41...

08.10.2025 17:17 πŸ‘ 24 πŸ” 8 πŸ’¬ 0 πŸ“Œ 0
Post image

A small primer on the #NobelPrize awarded to Mary E. Brunkow, Fred Ramsdell and Shimon Sakaguchi today. This prize was for combining two separate fields of immunology research - genetic research on IPEX and immunology research of regulatory T cells (#Tregs), with enormous impact on biology/medicine

06.10.2025 11:21 πŸ‘ 154 πŸ” 72 πŸ’¬ 2 πŸ“Œ 12
Preview
The official website of the Nobel Prize - NobelPrize.org The Nobel Prize rewards science, humanism and peace efforts. This is one of the central concepts in the will of Alfred Nobel, and it also permeates the outreach activities that have been developed for the purpose of engaging, inspiring and spreading knowledge about the Nobel Prize as well as the discoveries and achievements of the laureates.

The Nobel Assembly at Karolinska Institutet has decided to award the 2025 Nobel Prize in Physiology or Medicine to:

Mary E. Brunkow, Fred Ramsdell, Shimon Sakaguchi

β€œfor their discoveries concerning peripheral immune tolerance”

06.10.2025 09:48 πŸ‘ 22 πŸ” 12 πŸ’¬ 2 πŸ“Œ 0
A photo of a Nobel medal

A photo of a Nobel medal

BREAKING: The Nobel Prize in Physiology or Medicine has been awarded jointly to Mary E. Brunkow, Fred Ramsdell, and Shimon Sakaguchi "for their discoveries concerning peripheral immune tolerance"

Stay tuned for more.
#NobelPrize

06.10.2025 09:34 πŸ‘ 224 πŸ” 95 πŸ’¬ 1 πŸ“Œ 13
Post image

If the immune system is an army...
...
would you rather rely on one β€œsuper warrior” β€” or on a diverse team of fighters, even if none of them is the single strongest?

I’d go with the team.

Why? Check out our new study, just published in Science Immunology: www.science.org/doi/10.1126/...

03.10.2025 18:07 πŸ‘ 73 πŸ” 21 πŸ’¬ 5 πŸ“Œ 1